arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SkinHealth Systems Inc.

SKIN
$10.32 ▼ -0.95 (-8.43%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
28 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

SkinHealth Systems Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3B
Dividend Yield —
Revenue Growth -7.8% ↘
Op. Margin 5.0% ↗
ROIC 11.7% ↗
FCF / Share $0.02 ↗
Trailing P/E —
Price / Book 24.2x
FCF Yield 0.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.11M
↓ -7.8% —
Net Income Profit after all expenses
$-6.63M
↑ +34.3% —
Operating Margin Operating profit as % of sales
5.0%
↑ +278.5% 18th
FCF / Share Free cash flow per share
$0.02
↑ +138.3% —
Long-Term Debt Long-term obligations
$363.39M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
37
Returns ↑
30
Financial Health ↑
44
Cash Quality
4

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 28 quarters